Corbus Pharmaceuticals Holdings Inc

NASDAQ: CRBP
$18.68
+$0.16 (+0.9%)
Real Time Data Delayed 15 Min.

CRBP Stock Chart and Intraday Price

CRBP Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 100 RIVER RIDGE DRIVE, NORWOOD, MA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 361.79M USD
Shares Outstanding 10,336,800
Corbus Pharmaceuticals Holdings Inc is a pioneering biopharmaceutical company focused on creating innovative treatments for serious illnesses. With a robust pipeline that includes CRB-701, a targeted therapy for cancer, and lenabasum, a novel treatment for inflammation and fibrosis, Corbus is at the forefront of medical research. The company also explores treatments for obesity and related metabolic diseases with CRB-913. Based in Norwood, Massachusetts, and founded in 2009, Corbus is committed to advancing healthcare through groundbreaking research and partnerships, such as its collaboration with Jenrin Discovery, LLC.

CRBP Articles

Public offerings of stock and activist investor activity prompted some huge insider buying at an entertainment company, an airline, biotechs, and more.
A public offering of shares this past week prompted a huge purchase from a beneficial owner. Meanwhile, a couple of repeat buyers further boosted their stakes as well.
The release of OpenAI‘s ChatGPT chatbot in November 2022 unleashed a frenzy of investor interest in artificial intelligence that propelled Nvidia (NASDAQ:NVDA) to the forefront of the industry. The...
Warren Buffett boosts his stake in this tracking stock again, plus notable insider buying of communication and aviation stocks in the past week.
Another huge Warren Buffett purchase highlighted the past week's insider buying, and a couple of IPOs also prompted insiders to action.
As January wound to a close, beneficial owners, executives, and other insiders took advantage of public offerings of stock at these biotech companies.
Robinhood has become the dominant discount brokerage platform over the last year. It had 4.3 million average revenue trades in June, which is a critical metric in the industry. This is higher than...